Dilip Shanghvi

Dilip Shanghvi
Dilip Shanghvi
Born	October 1, 1955 (age 71); Kolkata, India
Occupation(s)	Entrepreneur, Businessman
Known for	Founder of Sun Pharmaceuticals
Notable work	The Reluctant Billionaire (biography)

Dilip Shanghvi (born 1 October 1955) is an Indian billionaire entrepreneur and the founder of Sun Pharmaceuticals, a prominent pharmaceutical firm. In 2016, the Government of India honored him with the prestigious civilian award, the Padma Shri. India Today placed him eighth on its list of India's most influential individuals in 2017. As reported by Forbes in May 2025, Shanghvi ranks as the fifth wealthiest person in India, with an estimated net worth of US$28.9 billion.

Early life

Originating from a Jain family in Gujarat, Shanghvi was brought up in Kolkata, where his father managed a modest wholesale enterprise dealing in generic medications. He completed his schooling at J. J. Ajmera High School and obtained a Bachelor of Commerce degree from the University of Calcutta. His early exposure to the family’s pharmaceutical distribution business offered valuable industry experience, inspiring him to shift focus from trading to manufacturing pharmaceuticals.

Career

Following his tenure in his father’s pharmaceutical distribution venture in Kolkata, Dilip Shanghvi established Sun Pharmaceutical Industries in 1983, funded by a small loan from his father. The company initially concentrated on producing psychiatric medications and operated from a single manufacturing unit located in Vapi, Gujarat.

Sun Pharma steadily diversified its product portfolio and expanded into new markets. By 1993, rising earnings facilitated investments into dedicated research and development centers.

Under Shanghvi’s guidance, Sun Pharma pursued strategic acquisitions, including the significant $4 billion acquisition of Ranbaxy Laboratories in 2014. This deal elevated Sun Pharma to become India’s largest pharmaceutical company and a leading global player in generic drugs.

Despite facing regulatory hurdles and profit declines between 2014 and 2018, Shanghvi successfully steered the company back to growth. By 2023, Sun Pharma achieved profits exceeding ₹8,000 crore, largely fueled by robust expansion in specialty pharmaceuticals.

Shanghvi also spearheaded international acquisitions such as the US-based Ocular Technologies in 2016 and Concert Pharmaceuticals in 2023, broadening Sun Pharma’s footprint in the specialty drug sector worldwide.

Community

In January 2018, the Indian government appointed Shanghvi to serve on the central board committee of the Reserve Bank of India. He holds the position of chairman on the board of governors at IIT Bombay and was named a trustee of the Rhodes Scholarship programme at University of Oxford in 2017.

Personal life

Dilip Shanghvi was born into a Jain household and practices Jainism. He is married to Vibha Shanghvi and has two children, Aalok and Vidhi, both employed by Sun Pharmaceuticals. Despite his considerable fortune, he prefers to maintain a discreet public presence. A devout follower of Shrinathji, he frequently undertakes pilgrimages with his family to the deity’s shrine in Nathdwara, Rajasthan. Images of Shrinathji are prominently displayed across Sun Pharma’s factories and offices.

Book

In 2019, journalist Soma Das authored The Reluctant Billionaire, the inaugural biography of Dilip Shanghvi, published by Penguin Random House. This work was shortlisted for the Tata Literature Award under the Best Business Book category. Business Standard commended the book as "a compelling read," highlighting Das’s skill in portraying Shanghvi’s character authentically.

External links